Advertisement

Topics

Cancer Cytogenomics Microarray Consortium (CCMC) Company Profile

16:27 EDT 19th June 2018 | BioPortfolio

The Cancer Cytogenomics Microarray Consortium (CCMC) was formed in August 2009 by a group of clinical cytogeneticists, molecular geneticists, and molecular pathologists who are interested in applying microarray technologies to cancer diagnosis and cancer research.
The mission of the consortium is to promote communication and collaboration among cancer cytogenomics laboratories. Our goals are to: (1) establish platform-neutral and cancer specific microarray designs for diagnostic purposes, (2) foster collaboration between participating institutions (3), create a public cancer array database and, (4) carry out multi-center cancer translational research. This will ultimately better serve cancer patients and advance the field of cancer genomics.

The CCMC has more than 300 members from over 150 organizations in the U.S., Canada, and abroad.

Location

University of Rochester Medical Center
601 Elmwood Ave, Rochester,
Rochester
NY
14642
USA

Contact

Phone: (585) 275-1077
Fax: (585) 273-3360
Email: Anwar_Iqbal@urmc.rochester.edu


News Articles [2672 Associated News Articles listed on BioPortfolio]

DNA Microarray for AgricultureEMEA Market Status and Trend Report 20132023 [Report Updated: 08012018] Prices from USD $3480

Report SummaryDNA Microarray for AgricultureEMEA Market Status and Trend Report 20132023 offers a comprehensive analysis on DNA Microarray for Agriculture industry, standing on the readers' perspectiv...

DNA Microarray for AgricultureGlobal Market Status and Trend Report 20132023 [Report Updated: 08012018] Prices from USD $2480

Report SummaryDNA Microarray for AgricultureGlobal Market Status and Trend Report 20132023 offers a comprehensive analysis on DNA Microarray for Agriculture industry, standing on the readers' perspect...

C-Path receives COA qualification from FDA for the non-small cell lung cancer SAQ

(Critical Path Institute (C-Path)) Critical Path Institute's (C-Path) Patient-Reported Outcome (PRO) Consortium announces its second clinical outcome assessment (COA) qualification from the US Food an...

DNA Microarray for AgricultureIndia Market Status and Trend Report 20132023 [Report Updated: 08012018] Prices from USD $2980

Report SummaryDNA Microarray for AgricultureIndia Market Status and Trend Report 20132023 offers a comprehensive analysis on DNA Microarray for Agriculture industry, standing on the readers' perspecti...

DNA Microarray for AgricultureChina Market Status and Trend Report 20132023 [Report Updated: 08012018] Prices from USD $2980

Report SummaryDNA Microarray for AgricultureChina Market Status and Trend Report 20132023 offers a comprehensive analysis on DNA Microarray for Agriculture industry, standing on the readers' perspecti...

DNA Microarray for AgricultureSouth America Market Status and Trend Report 20132023 [Report Updated: 08012018] Prices from USD $3480

Report SummaryDNA Microarray for AgricultureSouth America Market Status and Trend Report 20132023 offers a comprehensive analysis on DNA Microarray for Agriculture industry, standing on the readers' p...

DNA Microarray for AgricultureNorth America Market Status and Trend Report 20132023 [Report Updated: 08012018] Prices from USD $3480

Report SummaryDNA Microarray for AgricultureNorth America Market Status and Trend Report 20132023 offers a comprehensive analysis on DNA Microarray for Agriculture industry, standing on the readers' p...

DNA Microarray for AgricultureUnited States Market Status and Trend Report 20132023 [Report Updated: 08012018] Prices from USD $3480

Report SummaryDNA Microarray for AgricultureUnited States Market Status and Trend Report 20132023 offers a comprehensive analysis on DNA Microarray for Agriculture industry, standing on the readers' p...

PubMed Articles [6321 Associated PubMed Articles listed on BioPortfolio]

Rationale for the Cytogenomics of Cardiovascular Malformations Consortium: A Phenotype Intensive Registry Based Approach.

Cardiovascular malformations (CVMs) are the most common birth defect, occurring in 1%-5% of all live births. Although the genetic contribution to CVMs is well recognized, the genetic causes of human C...

Analgesic Use and Ovarian Cancer Risk: An Analysis in the Ovarian Cancer Cohort Consortium.

Aspirin use is associated with reduced risk of several cancers. A pooled analysis of 12 case-control studies showed a 10% decrease in ovarian cancer risk with regular aspirin use, which was stronger f...

No association between circulating concentrations of vitamin D and risk of lung cancer: An analysis in 20 prospective studies in the Lung Cancer Cohort Consortium (LC3).

There is observational evidence suggesting that high vitamin D concentrations may protect against lung cancer. To investigate this hypothesis in detail, we measured circulating vitamin D concentration...

HPV infection and breast cancer. Results of a microarray approach.

Human papilloma virus (HPV) has been implicated in several types of epithelial cancer. The role of HPV in breast carcinogenesis has been a matter of debate fueled by conflicting reports in recent year...

Vertebrate Genome Evolution in the Light of Fish Cytogenomics and rDNAomics.

To understand the cytogenomic evolution of vertebrates, we must first unravel the complex genomes of fishes, which were the first vertebrates to evolve and were ancestors to all other vertebrates. We ...

Clinical Trials [8020 Associated Clinical Trials listed on BioPortfolio]

Linkage Consortium for End-Stage Renal Disease

The Family Investigation of Nephropathy and Diabetes (FIND)Study is a multi-center consortium. The charge of the consortium is to acquire sets of families with well-characterized diabetic ...

DNA Microarray Study of Pancreas Cancer

Pancreas cancer and precancerous cysts can be difficult to diagnose. Sometimes biopsies do not show cancer when cancer is actually present. We hypothesize that genetic differences exist in...

Study of Sperm Molecular Factors Implicated in Male Fertility

Sperm analysis following World Health Organization guidelines is unable to explain the molecular causes of male infertility when basic sperm parameters are within a normal range and women ...

Lynne Cohen Consortium Project: Multi-Center Database/Registry

Goals of this registry: 1.1 To collect and store very limited demographic information (age, birthdate, race and ethnicity), limited cancer risk and breast and ovarian disease history, as ...

Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma

This study will investigate gene expression profiles in normal human lung tissue, lung carcinoma and metastatic tumor to the lung. The expression of up to 20,000 genes in a given lung tis...

Companies [1629 Associated Companies listed on BioPortfolio]

Cancer Cytogenomics Microarray Consortium (CCMC)

The Cancer Cytogenomics Microarray Consortium (CCMC) was formed in August 2009 by a group of clinical cytogeneticists, molecular geneticists, and molecular pathologists who are interested in applyin...

WIN Consortium

The WIN Consortium (www.winconsortium.org) is a joint initiative of Institut Gustave Roussy (France) and University of Texas - MD Anderson Cancer Center (USA) which brings togethe...

DNA Microarray (Genome Chip)

Welcome to the DNA Microarray (Genome Chip) Web site! This simple, printer-friendly site has been created and maintained by Leming Shi, Ph.D. You'll find the basics on DNA microarray technology and a ...

Industrial Internet Consortium

The Industrial Internet Consortium® is an open membership organization with over 200 members from 26 countries, formed to accelerate the development, adoption, and wide-spread ...

The Cancer Information Service Research Consortium

More Information about "Cancer Cytogenomics Microarray Consortium (CCMC)" on BioPortfolio

We have published hundreds of Cancer Cytogenomics Microarray Consortium (CCMC) news stories on BioPortfolio along with dozens of Cancer Cytogenomics Microarray Consortium (CCMC) Clinical Trials and PubMed Articles about Cancer Cytogenomics Microarray Consortium (CCMC) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cancer Cytogenomics Microarray Consortium (CCMC) Companies in our database. You can also find out about relevant Cancer Cytogenomics Microarray Consortium (CCMC) Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...


Corporate Database Quicklinks



Searches Linking to this Company Record